Skip to content

Effect of recombinant thrombomodulin (ART123) for sepsis with disseminated intravascular coagulation

Effect of recombinant thrombomodulin (ART123) for sepsis with disseminated intravascular coagulation - Effect of rTM for sepsis with DIC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003799
Enrollment
80
Registered
2010-07-01
Start date
2010-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe sepsis, septic shock, sepsis with disseminated intravascular coagulation

Interventions

administration of recombinant thrombomodulin administration of saline

Sponsors

Tokyo Medical and Dental University Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: svere sepsis and septic shock with acute DIC score more than 4 points

Exclusion criteria

Exclusion criteria: hemorrhagic complication pregnant

Design outcomes

Primary

MeasureTime frame
28-day mortality hemorrhagic event

Secondary

MeasureTime frame
28-day ICU mortality SOFA score data of coagulation (platelet, PT-INR, fibrinogen, FDP, TAT, PIC, ATIII, protein C, protein S) data of inflammation (CRP, procalcitonin, IL-1beta, IL-6, TNF-alfa, HMGB1) resolution rate of JAAM DIC score weaning rate of mechanical ventilator

Countries

Japan

Contacts

Public ContactToshiki SERA

Tokyo Medical and Dental University Medical Hospital Shock, Trauma, and Critical Care Center

seraaccm@tmd.ac.jp03-5803-5102

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026